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In neuronal cells, activated glucocorticoid receptor
(GR) translocates to the nucleus guided by the cy-
toskeleton. However, the detailed mechanisms un-
derlying GR translocation remain unclear. Using
gain and loss of function studies, we report here
for the first time that the microtubule-associated
protein doublecortin-like (DCL) controls GR trans-
location to the nucleus. DCL overexpression in
COS-1 cells, neuroblastoma cells, and rat hip-
pocampus organotypic slice cultures impaired GR
translocation and decreased GR-dependent tran-
scriptional activity, measured by a specific re-
porter gene assay, in COS-1 cells. Moreover, DCL
and GR directly interact on microtubule bundles
formed by DCL overexpression. A C-terminal trun-
cated DCL with conserved microtubule-bundling
activity did not influence GR translocation. In N1E-
115 mouse neuroblastoma cells and neuronal pro-
genitor cells in rat hippocampus organotypic slice
cultures, laser-scanning confocal microscopy
showed colabeling of endogenously expressed
DCL and GR. In these systems, RNA-interference-
mediated DCL knockdown hampered GR translo-
cation. Thus, we conclude that DCL expression is
tightly regulated to adequately control GR trans-
port. Because DCL is primarily expressed in neu-
ronal progenitor cells, our results introduce this
microtubule-associated protein as a new modula-
tor of GR signaling in this cell type and suggest the
existence of cell-specific mechanisms regulating
GR translocation to the nucleus. (Molecular Endo-
crinology 22: 248–262, 2008)
IN THE HIPPOCAMPUS, adrenal corticosteroids ex-ert profound effects on neurogenesis, cognitive pro-
cesses, and adaptation to stress. These actions are
mediated by two related receptor molecules, the min-
eralocorticoid receptor and the glucocorticoid recep-
tor (GR) (1). In the cytosol, the GR is part of a protein
heterocomplex designated transportosome, consist-
ing of chaperone proteins such as heat shock protein
90 (hsp90) (2), immunophilins, and dynein (3). Upon
glucocorticoid (GC) binding, the transportosome com-
plex remodels and translocates the activated GR to
the nucleus using microtubule tracks (4). However,
beyond the involvement of heat shock proteins, im-
munophilins, and dynein, little is know about cell type-
specific factors regulating GR translocation. In the hip-
pocampus, quiescent neuronal progenitor cells
(NPCs) are GR positive (5). Exposure of these NPCs to
the GR agonist dexamethasone (DEX) inhibits their
proliferation (6). However, how GR signaling is regu-
lated in NPCs is not yet completely understood.
Doublecortin-like (DCL), a splice variant of the DCLK
gene, is expressed in NPCs with high specificity (7–9).
Products of the DCLK gene are involved in mitotic
spindle formation, accurate cell cycle progression,
and stability of cellular processes in NPCs (8, 9). More-
over, DCLK may regulate microtubule-based vesicle
transport (10), and in vitro data have shown direct
protein-protein interaction between dynein and prod-
ucts of the DCLK gene (8). DCL is a microtubule-
associated protein (MAP) that exhibits high sequence
identity with doublecortin (DCX), which plays a crucial
role in neuronal migration by interacting with tubulin
and other proteins, including dynein (9, 11). Exoge-
nous DCL overexpression in cell lines induces a
marked microtubule bundling (8, 9).
Based on previous evidence demonstrating that GR
translocates to the nucleus on microtubule tracks in a
dynein-dependent manner (12), we speculated that
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DCL is involved in GR translocation to the nucleus. To
test this hypothesis, we over-expressed DCL with a
previously characterized N-terminal yellow fluorescent
protein-tagged GR (YFP-GR) (13) in COS-1 cells and in
neuroblastoma cells and NPCs in rat hippocampus
organotypic slice (OTS) cultures, both endogenously
expressing GR. Similar systems have been extensively
used to study GR translocation to the nucleus (14, 15).
In addition, we used short hairpin RNA-mediated RNA
interference to down-regulate DCL expression in N1E-
115 mouse neuroblastoma cells and in OTS cultures
from early postnatal rat hippocampus. Our results re-
veal a function for DCL in GR translocation to the
nucleus and therefore, for the first time, provide evi-
dence supporting the involvement of cell type-specific
MAPs, particularly from the doublecortin domain-con-
taining family, in regulation of GR signaling.
RESULTS
DCL Overexpression Impairs GR Translocation to
the Nucleus in COS-1 Cells
To study DCL interaction with GR, YFP-GR was co-
transfected with DCL in COS-1 cells. As neither GR
(13) nor DCL (9) is endogenously expressed in COS-1
cells, they provide an excellent system with which to
study DCL-GR interactions. Cells were cotransfected
with YFP-GR and the empty pcDNA 3.1 vector as
experimental control. Transfected cells were exposed
to 1  107 M DEX or the GR antagonist RU486,
both known to induce nuclear translocation of the
receptor (16).
Observation of pcDNA 3.1-DCL and YFP-GR coex-
pressing cells showed a clear retention of YFP-GR on
the microtubule bundles induced by DCL expression,
as compared with control cells (Fig. 1, A and B). DEX
and RU486 induced YFP-GR translocation to the nu-
cleus with a calculated t1/2 of 10.7 1.5 min and 8.7
0.5 min, respectively at 37 C (Fig. 1C). This effect was
readily observed as soon as 10 min after DEX treat-
ment (Fig. 1C). A complete YFP-GR translocation was
reached after 30 min and lasted for at least 1 h in the
presence of the ligand in control cells (Fig. 1C). Coex-
pression of pcDNA 3.1-DCL induced a significant de-
crease in the maximal amount of ligand-induced
YFP-GR translocation to the nucleus 30 min after li-
gand application (41.3  5.4% and 43.6  3.1% de-
crease, DEX and RU486, respectively; n 3, P 0.05)
(Fig. 1C). The half-lives of the translocated fractions
induced by DEX and RU486 were not significantly
different from those observed in control cells (10.99 
2.8 min DEX, 10.32 1.7 RU486 vs. and 8.75 3.2 min
DEX, 7.78  3.8 RU486, respectively; n  3) (Fig. 1C).
Consistent with these observations, coexpression
of pcDNA 3.1-DCL with YFP-GR induced a significant
reduction in the maximal GR-dependent transcrip-
tional activity induced by DEX treatment (38.25 
3.5% decrease; n  3, P  0.05), without affecting its
pEC50 value (8.3  0.3 vs. 8.6  0.2, with and without
pcDNA 3.1-DCL, respectively; n  3) as measured by
a dual luciferase GR-reporter gene assay (Fig. 1D).
This last observation suggests that the presence of
DCL did not affect GR binding affinity for DEX. DEX-
induced GR-dependent transcriptional activity was
specifically blocked by incubation with 1  107 M
RU486, whereas vehicle-treated cells showed no ef-
fect (data not shown).
These results were confirmed by cotransfection of
YFP-GR with a DCL C-terminal fusion protein to the
red fluorescent protein DsRed2 (DCL-DsRed2) and
time-lapse confocal microscopy on live cells, showing
a clear retention of YFP-GR on the DCL-DsRed2-in-
duced microtubule bundles after 1  107 M DEX
application (supplemental video 1 published as sup-
plemental data on The Endocrine Society’s Journals
Online web site at http://mend.endojournals.org).
Interestingly, in a significant proportion of cells ex-
pressing DCL, YFP-GR formed globular hotspots of
protein accumulation on the microtubule bundles after
DEX treatment (Fig. 1B). Laser scanning confocal mi-
croscopy showed that DCL-DsRed2 and YFP-GR
were colocalized on microtubule bundles formed by
DCL in vehicle-treated cells (Fig. 2A). The hotspots of
protein accumulation induced by DEX treatment (30
min, 1  107 M) displayed a high degree of YFP-GR
colocalization with DCL-DsRed2 (Fig. 2B). Formation
of similar globular accumulations on microtubule
tracks containing activated GR has been previously
described associated with treatment with the hsp90
inhibitor geldanamycin (17).
The C-terminal serine/proline-rich domain of DCX,
which shares high amino acid identity with DCL (9), is
involved in protein-protein interactions (18). Consis-
tent with this idea we mapped the DCL domain in-
volved in regulating GR translocation to the C-terminal
serine/proline-rich domain of DCL. Cotransfection of
COS-1 cells with YFP-GR and a DsRed2-tagged C-
terminal truncation of DCL, lacking the complete
serine/proline-rich domain (T285DCL-DsRed2), in-
duced microtubule bundling similar to full-length DCL
but had no effect on YFP-GR translocation to the
nucleus (Fig. 2, C and D).
Taken together, these results suggest that expres-
sion of DCL in COS-1 cells induced obstructions on
microtubule tracks that interfere with GR transport to
the nucleus.
To test for the specificity of these observations, we
performed a number of experimental controls (supple-
mental Fig. 1). These experiments demonstrated that:
1) the effect of DCL on YFP-GR translocation could
not be explained simply by a physical hindrance in-
duced by microtubule bundling; 2) DCL expression
does not interfere with GR coupling to hsp90; 3) the
effects of DCL on YFP-GR translocation are not a
consequence of a general cytoskeleton disarrange-
ment. Therefore, the effects of DCL on GR transloca-
tion seem to be the result of a specific mechanism,
most likely involving protein-protein interactions
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through the C-terminal serine/proline-rich domain of
DCL.
To further characterize DCL interaction with the GR,
we performed biochemical assays to study protein
interaction. HeLa cells, which endogenously express
the GR but not DCL (Fig. 3A), were transfected with
pcDNA3.1-DCL. GR and DCL coimmunoprecipitated
from transfected cells when the specific GR antibody
was used (Fig. 3B).
Next, we studied the intracellular location of the
observed GR-DCL interaction by Fo¨rster resonance
energy transfer (FRET) followed by pixel-by-pixel anal-
ysis of the FRET images using EGFP/EYFP as donor/
acceptor pair (see Materials and Methods and supple-
mental Fig. 2). Previous to FRET experiments, YFP-GR
and EGFP-DCL were cotransfected in COS-1 cells and
controlled by Western blot (Fig. 3C). As shown in Fig.
2A, EGFP-DCL expression induced microtubule bun-
dling and a marked GR localization on these bundles,
demonstrating that colocalization is independent of
the nature or the location of the fluorescent tags.
Quantification revealed a significant increase in FRET
intensity in YFP-GR/EGFP-DCL cotransfected cells,
as compared with YFP-GR/empty pEGFP-C1 vector
cotransfected control cells (Fig. 3D). A detailed anal-
ysis of the FRET images revealed that the specific
interaction between EYFP-GR and EGFP-DCL takes
place mainly on the microtubule bundles induced by
DCL expression (Fig. 3, E and F). Moreover, EGFP
alone neither affected localization of YFP-GR nor in-
teracted with YFP-GR (Fig. 3F).
DCL Overexpression Impairs GR Translocation in
N1E-115 Neuroblastoma Cells
To verify that the observed effects of DCL expression
on GR translocation are not due to other factors ex-
pressed in COS-1 cells, we used the N1E-115 mouse
Fig. 1. DCL Expression Impairs GR Translocation to the Nucleus in COS-1 Cells
Time frame of GR translocation in the absence (A) or presence (B) of pcDNA 3.1-DCL (DCL). YFP-GR (green) and Hoechst
33342 (red). Scale bar, 32 m. Arrow indicates GR accumulations after DEX treatment on microtubule bundles induced by DCL.
C, Time frame of GR translocation induced by DEX and RU486 in the presence or absence of DCL. Results are expressed as
nucleus-cytosol translocation ratios and represent mean SEM of three independent experiments (100 cells scored in each). ROD,
Relative OD. D, DEX-induced GR-dependent transcriptional activity in the presence or absence of DCL, normalized to the maximal
response detected in the absence of DCL.
250 Mol Endocrinol, February 2008, 22(2):248–262 Fitzsimons et al. • DCL Modulates GR Transport
neuroblastoma cell line, which endogenously ex-
presses GR and DCL (9, 19 ). We used dimethylsulf-
oxide (DMSO)-differentiated N1E-115 cells (20), the
long neurites of which facilitated visualization and per-
mitted study of the role of DCL in GR transport to the
nucleus.
The GR transportosome includes, among other pro-
teins, cytoplasmatic dynein, the motor protein respon-
sible for its retrograde transport to the nucleus (12).
Therefore, we used laser-scanning confocal micros-
copy analysis of DMSO-treated N1E-115 cells to study
possible DCL, GR, and dynein colocalization. As pre-
viously shown (9) we found native DCL largely colo-
calized with tubulin and strongly present and distrib-
uted along neurites of differentiated cells, suggesting a
function in these structures (Fig. 4A). In neurites, DCL
colocalized with GR (Fig. 4B) and dynein intermediate
chain (Fig. 4C).
DCL-DsRed2 overexpression resulted in a cellular
phenotype characterized by microtubule bundling, cell
flattening, and changes in cells morphology (Fig. 4,
D–G). The endogenous GR accumulated on the mi-
crotubule bundles induced by DCL overexpression.
Treatment of the cells with 1  107 M DEX (30 min)
did not result in visible changes in GR localization, with
GR still strongly colocalized to DCL on microtubule
bundles, as compared with vehicle-treated cells (Fig.
4, D and E).
Conversely, in control cells transfected with empty
DsRed2 (pDsRed2-N1 vector), treatment with 1 
107 M DEX (30 min) resulted in GR depletion form
neurites and accumulation in the nuclear and perinu-
clear area (Fig. 4, F and G).
DCL Knockdown Affects GR Translocation in
N1E-115 Neuroblastoma Cells
Next, we studied the effect of DCL knockdown on GR
translocation in N1E-115 cells, a system with native
stoichiometry. We used pS-DCL, a previously de-
scribed pSUPER-based plasmid encoding a perfect
match short hairpin RNA against DCL, and its mis-
matched control pS-DCLm for successive experi-
ments (9).
pS-DCL down-regulated, in a dose-dependent
manner, the expression of endogenous DCL at the
mRNA level as measured by qPCR (Fig. 5A) and at the
protein level as measured by Western blot (Fig. 5B).
This dose dependency suggested that increasing the
expression levels of DCL could counteract the effects
of pS-DCL. Effectively, overexpression of DCL-
DsRed2 (1 g/1  106 cells) restored, albeit only
partially, DCL expression levels (Fig. 5B). pS-DCLm
did not have significant effects on DCL expression
(Fig. 5, A and B). pS-DCL did not influence the expres-
sion of -tubulin (Fig. 5B) or -actin (data not shown),
suggesting that its effects were specific for DCL.
For GR translocation studies, cells were cotrans-
fected with pEBFP-C1 as transfection control (data
not shown) and pS-DCL or pS-DCLm (1:5). Cells were
exposed, 24 h after transfection, to 2% DMSO for 5 d.
On the fourth day medium was changed to culture
medium containing 2% charcoal-activated stripped
fetal bovine serum and 2% DMSO. On the fifth day
Fig. 2. YFP-GR Retention onMicrotubule Bundles Is Depen-
dent on the Presence of DCL C-Terminal Serine/Proline-Rich
Domain
Colocalization of YFP-GR (green) and DsRed2-DCL (red)
on microtubule bundles formed by DCL in vehicle-treated (A)
and DEX-treated (B) COS-1 cells. Arrows indicate protein
accumulation containing GR and DCL. C, YFP-GR (green)
translocation to the nucleus (Hoechst 33342, blue) in the
presence of C-terminal truncated DCL (red). D, Schematic
representation of DCL-DsRed2 and its T285 truncated form.
Scale bars, 20 m in A and B; 32 m in C. In all cases, one
representative confocal plane is shown. S/P, Serine/proline-
rich domain.
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cells were exposed to 1  107 DEX or vehicle for 30
min at 37 C and immediately fixed.
Laser-scanning confocal microscopy demonstrated
a large amount of GR still retained in neurites of pS-
DCL transfected cells after DEX incubation (Fig. 5C). In
comparison, upon DEX treatment GR was significantly
depleted from neurites and accumulated in the nu-
cleus and perinuclear area in pS-DCLm-transfected
cells (Fig. 5D). Neurites seemed structurally not af-
fected by DCL down-regulation as revealed by -tu-
bulin staining (Fig. 5, C and D).
In pS-DCL transfected cells, after DEX treatment
colocalization of GR to tubulin in neurites was signifi-
cantly higher than in pS-DCLm-transfected cells (Fig.
5E, colocalization scores 0.55  0.09 vs. 0.08  0.06,
respectively; P  0.05, 100 cells) or mock (pSuper)
transfected cells (Fig. 5E, colocalization scores 0.55
0.09 vs. 0.05 0.05, respectively; P 0.05, 100 cells).
Similarly, DEX-induced GR translocation to the nu-
cleus was significantly reduced as compared with
cells transfected with pS-DCLm (73.4  18.6%; 100
cells per condition; P  0.05; Fig. 5F). The transcrip-
tional activity of the endogenous GR was increased in
a dose-dependent manner by DEX (pEC50  8.01 
0.73; n  4), as measured by a specific GR reporter
gene assay. This DEX-induced increase in GR tran-
scriptional activity was dose-dependently blocked in a
dose-dependent manner by RU486 (pEC50  8.20 
0.36; n  4), providing a pharmacologically well-char-
acterized system with which to study GR-dependent
transcriptional activity. Transfection with pS-DCL signif-
icantly decreased DEX-stimulated GR-dependent tran-
scriptional activity as compared with pS-DCLm-trans-
fected cells (53.9  7.72%; n  3; P  0.05; Fig. 5G).
Mitochondria labeled with MitoTracker Red CMXR
(Invitrogen BV, Breda, The Netherlands) were evenly
Fig. 3. DCL Directly Interacts with GR
Coimmunoprecipation of GR and DCL from transfected (A) Hela cells, endogenously express GR but not DCL (10% of the input
used in B). B, Western blot detection of GR and DCL after immunoprecipitation with GR antibody from lysates of transfected Hela
cells. NI IgG, Rabbit nonimmune IgG. C, COS-1 cells transfected with YFP-GR, EGFP-DCL, or both previous to FRET experi-
ments. In all cases figures show a representative gel of four run independently. D, Mean normalized FRET intensities (NFRET) from
cells cotransfected with EGFP-DCL and YFP-GR (black bar) or with pEGFP-C1 and YFP-GR (white bar). Results represent mean
SEM of 36 cells each, from three independent experiments. *, Significantly different. Linearly unmixed cell images and the
corresponding pseudo-colored NFRET image to improve visualization, showing highest NFRET intensities on microtubule
bundles in cells coexpressing EGFP-DCL and YFP-GR (panel E) or undetectable NFRET in cells coexpressing EGFP and YFP-GR
(panel F). Color bar represents NFRET intensity scale. IB, Immunoblotting; IP, immunoprecipitation; Transf., transfection.
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distributed along neurites and present in the soma and
neurite extremities in pS-DCL and in pS-DCLm-trans-
fected N1E-115 cells (supplemental Fig. 3). These ob-
servations suggest that DCL down-regulation does
not significantly influence mitochondria transport,
which has been shown to be affected by other MAPs
involved in microtubule-dependent transport (21).
DCL Overexpression Impairs GR Translocation in
NPCs of Early Postnatal Rat Hippocampal
Organotypic Slices
DCLK is one of the most enriched MAPs in NPCs
present in the developing brain (8), a cell type in which
the GR controls cell proliferation (6). To study a pos-
sible role of DCL in GR transport to the nucleus in
NPCs, we used OTS cultures. In the present work we
focused on the hilus of the developing dentate gyrus
formation, where most NPCs are localized, generating
neurons that migrate to form the granular layer (22).
OTSs were transduced with the modified lentiviral
vector LV-DCL-DsRed2 to induce DCL overexpres-
sion. Four days after transduction (day in vitro 5, DIV5),
slices were processed and GR translocation was mea-
sured in DCL-DsRed2-expressing hilar cells showing a
phenotype with bundled microtubules (Fig. 6).
DCL overexpression in these cells induced a
marked colocalization of GR to the microtubule bun-
dles induced by DCL-DsRed2 expression. Interest-
ingly, treatment with 1 107 M DEX for 30 min did not
induce significant changes in GR localization, with GR
retained on DCL-DsRed2-containing bundles (Fig. 6A),
as observed in vehicle-treated cells (Fig. 6B). Con-
versely, in OTSs transduced with the LV-DsRed2 len-
tiviral vector, treatment with 1 107 M DEX for 30 min
induced a significant decrease in GR localization to
DsRed2 and accumulation in the cells soma and nu-
clear areas, whereas GR was diffusely expressed in
vehicle-treated DsRed2-expressing cells (Fig. 6, C and
D).
To further characterize these observations we quan-
tified DCL-DsRed2 or DsRed2/GR colocalization in
processes of DCL-DsRed2 or DsRed2 cells, respec-
tively, by using the Overlap Coefficient R method (see
Materials and Methods).
Colocalized pixels were represented in a black and
white bitmap using ImageJ (Fig. 6E). In line with our
DCL overexpression data from COS-1 and N1E-115
Fig. 4. DCL Overexpression Impairs GR Translocation in N1E-115 Cells
Colocalization of endogenous: DCL (green) and tubulin (red) (A); GR (green) and DCL (red) (B); and dynein (green) and DCL (red)
(C) in neurites and soma of DMSO-differentiated cells. Vehicle (D) or DEX-induced (E) GR (green) translocation in cells transfected
with DCL-DsRed2 (red). GR/tubulin colocalization scores were: 0.42  0.9 vs. 0.37  0.7, vehicle and DEX-treated cells,
respectively (mean  SEM of 72 cells scored in three independent experiments each). Vehicle (F) or DEX-induced (G) GR (green)
translocation in cells transfected with pDsRed2 (red). GR/tubulin colocalization scores were: 0.68  0.6 vs. 0.18  0.5, vehicle
and DEX-treated cells, respectively (mean SEM of 88 cells scored in three independent experiments each, significantly different).
Scale bars, 20 m in D and E; 32 m in F and G.
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cells, we noted retention of the GR on DCL-DsRed2-
containing bundles after DEX treatment, as compared
with vehicle-treated cells (Fig. 6F). A significantly in-
creased colocalization score in LV-DCL-DsRed2-
treated slices, as compared with LV-DsRed2-treated
slices was observed (0.52  0.15 vs. 0.1  0.12,
respectively; 43 processes counted in three indepen-
dent DEX-treated slices each).
DCL Knockdown Affects GR Translocation in
NPCs of Early Postnatal Rat Hippocampal
Organotypic Slices
To induce DCL knockdown, OTSs were transduced
with modified lentiviral vectors to deliver DCL short
hairpin RNA (LV-DCL) and its mismatch control (LV-
DCLm). Four days after transduction with LV-DCLm
(DIV5), DCL expression was detected in 87  9% of
the EGFP-positive cells phenotypically resembling
quiescent NPCs in the adult subgranular zone (23).
However, in OTSs transduced with LV-DCL, 44  6%
of the EGFP-positive cells were DCL negative, sug-
gesting an effective, although partial, DCL knockdown
(Fig. 7, A and B).
After incubation in culture medium containing DEX
(1  107 M, 90 min), GR immunoreactivity was sig-
nificantly retained in the processes of LV-DCL-trans-
duced EGFP cells compared with LV-DCLm-trans-
duced cells (Fig. 7, C and D), indicating that DCL
knockdown in NPCs results in impairment of DEX-
stimulated GR translocation. Control LV-DCLm-trans-
duced cells, treated with vehicle in otherwise identical
experimental conditions, showed GR abundantly
present in cellular processes of EGFP cells, discard-
ing a nonspecific induction of GR transport to the
nucleus by transduction with LV-DCLm (Fig. 7D).
EGFP/GR colocalization analyses in processes of
EGFP cells revealed retention of the GR on cellular
processes after DEX treatment (Fig. 7, E and F), ob-
Fig. 5. DCL Down-Regulation Affects GR Translocation in N1E-115 Cells
A, Dose-dependent DCL mRNA down-regulation induced by pS-DCL, as compared with pS-DCLm. DCL levels were normal-
ized to the 18S subunit of rRNA. Results represent mean  SEM of three independent experiments performed in duplicate. F,
Dose-dependent DCL protein down-regulation induced by pS-DCL as compared with pS-DCLm and recovery of DCL expression
levels by cotransfection with DCL-DsRed2 (DCL-R). Results shown are from one representative experiment of three independent
ones performed in duplicates. Molecular weight markers are indicated on the left. C and D, DEX-induced GR (green) translocation
in neurites (tubulin, red) of pS-DCL or pS-DCLm-transfected cells. E, GR/tubulin colocalization scores after DEX treatment in
cellular processes in pS-DCL or pS-DCLm-transduced cells. Neurites were selected as areas of interest for score calculations.
Mock-transfected cells treated with DEX or vehicle are shown as experimental controls. *, Significantly different from mock-
transfected, vehicle-treated cells (Mock Veh). F, DEX-induced nucleus-cytosol GR translocation ratios in pS-DCLm- or pS-DCL-
transfected cells. (mean  SEM of three independent experiments; 100 cells scored in each). G, DEX-induced GR-dependent
transcriptional activity in pS-DCLm- or pS-DCL-transfected cells (mean  SEM of three independent experiments performed in
duplicates). Scale bars, 20 um. *, Significantly different. Tub., Tubulin; Veh., vehicle.
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served as a significant increase in colocalization score
in LV-DCL-treated slices, as compared with LV-
DCLm-treated ones (0.42  0.09 vs. 0.1  0.07, re-
spectively; 56 processes counted in three indepen-
dent DEX-treated slices each).
For neural progenitor characterization and morphol-
ogy, we used markers proposed for the adult hippocam-
pus (23). According to this classification, we focused our
studies on cells with nestin/glial fibrillary acidic protein
(GFAP) processes present in the early postnatal hilus
(Fig. 8A). Staining with a DCL antibody revealed a large
extent of colabeling with nestin (Fig. 8B) and, to a lesser
extent, with GFAP (Fig. 8C). A large proportion of the
nestin-positive processes showed colocalization with
DCL (74 7% of a total 266 processes counted in three
independent slices) (Fig. 8, B and D). A significantly
smaller proportion of the GFAP processes showed
colocalization with DCL (26  9%, of a total 248 pro-
cesses counted in three independent slices) (Fig. 8, C
and D). These results indicated that DCL is expressed in
most nestin/GFAP NPCs, which represented 44 
8% of the nestin-positive cellular processes of a total of
210 counted in three independent OTS cultures (Fig. 8, A
and D).
Fig. 6. DCL Overexpression Impairs GR Translocation in Rat Hippocampal Organotypic Slice Cultures
DEX- (A) or vehicle-induced (B) GR (green) translocation in DCL-DsRed2 (red)-expressing cells in LV-DCL-DsRed2-transduced
slices. Insets, GR/DCL colocalization on structures resembling microtubule bundles (arrowheads) or hotspots of protein accu-
mulation (arrows) observed in COS-1 cells (Fig. 2). DEX- (C) or vehicle-induced (D) GR (green) translocation in DsRed2
(red)-expressing cells in LV-DsRed2-transduced slices. Insets, arrowheads indicate GR/DCL colocalization spots in nuclear/
perinuclear areas (C) or cellular processes (D). E, Grayscale bitmaps from A and B (top) or C and D (bottom) showing
GR/EGFP-colocalized pixels. F, GR/DsRed2 colocalization scores in cellular processes in LV-DCL-DsRed2 or LV-DsRed-
transduced slices treated with vehicle or DEX. Cellular processes were selected as areas of interest for score calculations. *,
Significantly different. Scale bars, 20 m.
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To determine whether DCL was the main DCLK
isoform expressed in NPCs, we stained with a CPG16
antibody, recognizing calmodulin (CAM) kinase ho-
mology domain-containing DCLK isoforms.
Laser-scanning confocal microscopy of DCL-positive
cells in the hilus of the dentate gyrus (DIV5) revealed no
colocalization with the weak nuclear CPG16 signal de-
tected in NPCs (Fig. 8E), whereas the CPG16 antibody
specifically labeled NeuN-positive cells in DIV21 OTSs
(data not shown). These observations confirmed that
CAM kinase homology domain-containing DCLK iso-
forms are mainly not expressed in NPCs (24, 25). In line
with published data, Nestin/GFAP NPCs were also
negative for DCX (data not shown) (23).
Fig. 7. DCL Down-Regulation Affects GR Translocation in Rat Hippocampal Organotypic Slice Cultures
A, DCL (red) expression in LV-DCLm (EGFP, green)-transduced slices. B, DCL (red) expression in LV-DCL (EGFP, green)-
transduced slices. Inset, a group of EGFP-positive cells with complete (arrow) or partial (arrowhead) knockdown and their different
phenotype. C, DEX insensitivity in LV-DCL-transduced slices. Inset, GR (red) retention in processes of EGFP-positive (green) cells
(arrow). D, DEX-induced GR translocation in LV-DCLm-transduced slices. Inset, Nuclear accumulation of GR (red) in EGFP-
positive (green) cells (arrow). Nuclei are stained in blue (Hoechst); vehicle-treated cells are shown as negative control on left
panels. E, Grayscale bitmaps from panels C (top) and D (bottom) showing GR/EGFP colocalized pixels. F, GR/EGFP colocalization
scores in cellular processes in LV-DCL- or LV-DCLm-transduced slices. Cellular processes were selected as areas of interest for
score calculations. *, P  0.05. Scale bars, 20 m.
256 Mol Endocrinol, February 2008, 22(2):248–262 Fitzsimons et al. • DCL Modulates GR Transport
Fig. 8. Characterization of DCL-Expressing Cells in the Hilar Region of DIV5 Rat Hippocampal Organotypic Slice Cultures
A, Colocalization of GFAP (red) and nestin (green). B, Colocalization of DCL (red) and nestin (green). C, Colocalization of DCL
(red) and GFAP (green). D, Proportions of cellular processes positive for nestin, GFAP, and/or DCL. Cellular processes were
selected as areas of interest for score calculations. E, Characterization of DCLK isoforms expressed. Inset, weak signal observed
for kinase domain-containing isoforms (CPG16, green) and lack of colocalization to the DCL (red) in processes. F, Colocalization
of GR (green) and DCL (red). Inset, distribution of GR in cellular processes in vehicle-treated slices. G, DEX-induced GR
translocation. Inset, decrease in GR (green) localization in cellular processes (DCL, red) as compared with F. H, Grayscale bitmaps
from panels F (top) and G (bottom) and the corresponding GR/DCL colocalization scores in cellular processes. *, P  0.05. Scale
bars, 20 m in A, B, C, F, and G; 32 m in E.
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In line with recent reports describing the expression
of GR in NPCs (5, 6), we found that the vast majority of
DCL-positive NPCs were GR positive (82.7  9.5%
from a total of 278 cells counted in three independent
OTSs; Fig. 6F). Incubation in culture medium contain-
ing DEX (1  107 M, 90 min) induced a significant GR
translocation from the cellular processes to the nu-
clear and perinuclear area in these cells (Fig. 8, F and
G), leading to a marked decrease in colocalization of
GR to DCL in cellular processes (Fig. 8H).
As a whole, our results in OTSs suggest that DCL is
involved in GR translocation in NPCs.
DISCUSSION
In the present work, we have demonstrated that the
MAP DCL is involved in GR translocation to the nu-
cleus. Cytoplasmic GR is known to be part of large
protein heterocomplexes containing hsp90, immu-
nophilins, and motor proteins of the dynein family,
which, upon ligand binding, transport activated GR to
the nucleus using the microtubule cytoskeleton as a
guiding scaffold (4). The data presented here show, for
the first time, that a cell type-specific MAP, DCL, is an
important regulator of this transport system that ret-
rogradely conveys activated GR to the nucleus in
NPCs.
The role of the cytoskeleton and the associated
chaperone machinery designated transportosome in
GR translocation to the nucleus has remained contro-
versial (26, 27). Nevertheless, the hindrance induced
by the cytoskeleton-disrupting drug colchicine on GR
signaling is primarily attributable to perturbation of the
microtubule network (28). In vivo, MAPs control micro-
tubule dynamics in cellular processes in which micro-
tubules act as tracks for cellular motors and to gen-
erate force (29). Furthermore, a new role for MAPs in
regulating motor-based transport in neurons has been
recently proposed (30). Based on our present data, we
postulate that MAPs such as DCL are involved in GR
transport and provide the actual cell type-specific
control signals required for transport regulation.
In line with this concept, it has been suggested that
hippocampal cells may have unique transporting
mechanisms for accumulating GR in the nucleus (26),
a notion that is supported by the role of DCL in GR
translocation in NPCs. Indeed, differences in expres-
sion of MAPs and other cytoskeletal proteins in the
hippocampus have suggested region-specific func-
tions of the neuronal cytoskeleton (31).
Nevertheless, from the present set of data we can-
not exclude the possibility that the observed effects on
GR transport are a consequence of DCL down-regu-
lation on other cellular processes, e.g. cell differenti-
ation. In fact, our hypothesis that DCL is involved in
GR retrograde transport accommodates such a pos-
sibility, given the well-described changes in expres-
sion of diverse components of the cytoskeleton that
take place during neuronal differentiation, including
isoforms of the DCLK gene (7, 25). Thus, although our
observations altogether demonstrated a direct
DCL-GR interaction, the precise mechanism by which
DCL affects GR translocation remains to be fully
characterized.
In our experiments DCL overexpression induced im-
pairment of GR translocation to the nucleus, whereas
overexpression of a C-terminal truncated DCL did not
affect GR translocation. These observations point to
an involvement of the serine/proline-rich C-terminal
domain of DCL in interactions with the GR. Alterna-
tively, taking into account c-Jun N-terminal kinase
(JNK)-mediated phosphorylation of DCX in its C-ter-
minal domain (10) and JNK association with the GR
(32), interactions with members of the JNK signaling
cascade may be involved in DCL effects on GR trans-
location. Importantly, the C-terminal domain of DCX
and the corresponding homology domain of DCLK
have been linked through direct protein-protein inter-
actions with protein transport or receptor recycling
within migrating neurons (18, 33). In line with such a
model, studies have shown that DCX binding to mi-
crotubules leaves its C-terminal domain accessible for
interaction with other proteins (34). Based on the high
homology between DCX and DCL (9), it is likely that
similar features are present in DCL, but further exper-
iments are required to accurately identify direct inter-
action partner(s).
DCL down-regulation resulted in a significant im-
pairment of GR translocation to the nucleus along with
retention of GR in neurites and a significant reduction
in GR-dependent transcriptional activity in mouse
neuroblastoma cells. This seemingly contradictory ob-
servation is in line with reports showing that both
overexpression and down-regulation of DCLK have
similar biological effects (8), suggesting that a proper
stoichiometry is central to function of cytoskeleton
regulators from the family of doublecortin domain-
containing MAPs (29). One possible explanation could
be that overexpression of DCL generates protein ac-
cumulations on microtubules that may congest motor
protein-dependent cargo movement as reported for
other MAPs (30), whereas DCL knockdown depletes
microtubules of a protein possibly involved in motor
protein-dependent cargo movement.
Upon DCL down-regulation, mitochondria position-
ing was not affected, in line with observations showing
that DCX does not block kinesin-dependent transport
in neurons (29). Nevertheless, axonal transport of syn-
aptic vesicles is severely compromised in DCX/DCLK
knockout mice (11), indicating specific roles for pro-
teins of this family in microtubule-based cargo trans-
port. Moreover, DC-domain containing proteins have
been linked to protein transport or receptor recycling
within migrating neurons (18). Data presented herein
provide, for the first time, evidence supporting such
functions in NPCs.
In systems with endogenous expression, such as
mouse neuroblastoma cells and NPCs, DCL is neces-
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sary for adequate translocation of activated GR to the
nucleus. Comparable findings have been reported for
GR transportosome-associated immunophilins (3).
Additionally, we and others have identified the DCLK
gene and components of the GR transportosome such
as hsp90, dynein, and several immunophilins to be
GC-responsive genes (3, 35, 36). Accordingly, expres-
sion of different MAPs is altered by GC (37), and
exposure to high GC levels induces marked down-
regulation of MAPs in the developing baboon (38) and
sheep (39) brain. Thus, GR may control the expression
of regulators of its intracellular transport (3). Differen-
tial regulation of the expression of components of the
GR transportosome could add to a hitherto underes-
timated cell type-specific control of GR translocation.
As we show that the amount of GR translocated to the
nucleus directly influences GC-responsive element-
dependent transcription, DCL may be involved in reg-
ulating GC actions, particularly in NPCs where acti-
vated GR controls cell proliferation and neurogenesis
(5, 6).
Because neuronal differentiation of NPCs in the
adult dentate gyrus mimics that of embryonic NPCs
(40), our results may be of relevance for understanding
the effects of stress and GC on adult neurogenesis as
well. Suggestively, the DCLK gene has been recently
implicated in neurogenesis and neuronal migration (8,
9, 11). The molecular tools to manipulate DCL expres-
sion described herein open up the possibility to test
DCL functions in physiologically relevant models of
GC-regulated neurogenesis.
In conclusion, we report, for the first time, the in-
volvement of the cell type-specific MAP DCL in the
translocation of activated GR to the nucleus, which
has important implications for the effects that circu-
lating GC have on NPCs. The specific expression of
DCL in NPCs (9) and its involvement in GR transloca-
tion suggest a specialized system by which NPCs
react toward GC stimulation. The existence of a
broader MAP-dependent, cell-specific control of GR
translocation could help to explain cell type specificity
of GC actions on neuronal cells, particularly concern-
ing neurogenesis and adaptation to stress in the hip-
pocampus. Our current efforts are directed to further
characterize this mechanism.
MATERIALS AND METHODS
Vectors, Antibodies, and Reagents
YFP-GR was supplied by Dr. Cidlowski (National Institute of
Environmental Health Sciences, National Institutes of Health);
YFP-angiogenin was supplied by Dr. Xu (Zhejiang University
School of Medicine, China). DCL-DsRed2 was generated by
excising DCL cDNA from pcDNA 3.1-DCL (9) using XhoI/
BamHI and subcloning it into pDsRed2-N1 vector (Invitrogen
BV). The DCL C-terminal truncation T285DCL-DsRed2 was
generated from DCL-DsRed2 by PCR. EGFP-DCL was gen-
erated by excising DCL cDNA from pcDNA 3.1-DCL using
XhoI/BamHI and subcloning it into pEGFP-C1 vector (Invitro-
gen BV). pSuper-DCL (pS-DCL) and its mismatched control
pS-DCLm have been previously described (9). The modified
lentiviral vectors LV-DCL-DsRed2, LV-DCL, and its mis-
matched control LV-DCLmwere generated by subcloning the
double-stranded DNA short hairpins present in pS-DCL and
pS-DCLm into the lentiviral vector pLV-CMV-eGFP (41).
EGFP was replaced by DCL-DsRed2 in LV-DCL-DsRed2.
Lentivirus stocks were produced in 293FT cells using the
ViraPower Lentiviral Expression System (Invitrogen BV) fol-
lowing manufacturer’s instructions. Primary antibodies GR
(M-20) rabbit polyclonal antibody, dynein intermediate chain
mouse monoclonal antibody, and GFAP (2E1) mouse mono-
clonal antibody were from Santa Cruz Biotechnology, Inc.
(Santa Cruz, CA); GR (BuGR2) mouse monoclonal antibody
was from Abcam (Cambridgeshire, UK); DCLK (CaMKLK
Sn370) rabbit polyclonal antibody has been previously de-
scribed (9, 42); nestin mouse monoclonal antibody and
CPG16/CaM kinase VI mouse polyclonal antibody were from
BD Biosciences (Breda, The Netherlands), and -Tubulin
(Clone DM 1A) mouse monoclonal antibody was from Sigma-
Aldrich (Zwijndrecht, The Netherlands). Alexa Fluor488 or
Alexa Fluor594-conjugated secondary antibodies were from
Molecular Probes/Invitrogen (Breda, The Netherlands) and
horseradish peroxidase-conjugated secondary antibody was
from Santa Cruz Biotechnology, Inc. Dexamethasone (DEX),
RU486 (Mifepristone), and 17-allylamino-17-demethoxy-
geldanamycin (17-AAG) were from Sigma-Aldrich. Paclitaxel
(Taxol) was from Calbiochem/Merck Biosciences (UK). All
tissue culture supplies and media were from Invitrogen BV.
Cell Culture and Transfection
African green monkey kidney COS-1 cells and mouse neu-
roblastoma N1E-115 cells were cultured and transfected as
previously described (9, 43). Transfection efficiency, opti-
mized with pEGFP-C1, was routinely found to be 75–80%.
N1E-115 cells were induced to differentiate into a neuronal
phenotype by culture in DMEM, 100 U/ml penicillin, 100
g/ml streptomycin, and 2.5% fetal bovine serum in the
presence of 2% DMSO for 5 d when, in our hands, neurite
outgrowth was most strongly observed (20). Control cells
were cultured in the same medium without the addition of
DMSO. For all experiments involving GR translocation to the
nucleus and GR-dependent transcriptional activity, cells
were cultured in medium containing activated charcoal-
stripped fetal bovine serum 24 h before stimulation, as de-
scribed (44).
Rat Hippocampal Organotypic Slice Cultures, Lentiviral
Vector Transduction, and Pharmacological Treatments
Early postnatal rat hippocampal OTS cultures were prepared
from 4- to 6-d-old male Wistar rats (Charles River Laborato-
ries, Inc., Frankfurt, Germany) using the modified interface
culture method (45). At the time of the first medium change
(DIV1) hippocampal slices were inoculated with 10 l of the
lentiviral vector stocks. Slices were fixed 4 d later with 4%
paraformaldehyde for 1 h at 4 C and used for immunofluo-
rescence studies. For GR localization experiments, slices
were cultured in medium containing activated charcoal-
stripped horse serum 24 h before stimulation and then incu-
bated with DEX added to the culture medium to a final con-
centration of 1  107 M or vehicle (ethanol; maximum final
concentration in medium, 0.001%) for 90 min before fixation.
All experiments were carried out with the approval of the
Animal Care Committee of the Faculty of Medicine, Leiden,
The Netherlands (DEC no. 06036).
Real-Time Quantitative PCR
RNA was purified using Trizol (Invitrogen BV), cDNA was
synthesized using the iScript cDNA synthesis kit (Bio-Rad
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Laboratories, Veenendaal, The Netherlands), and real-time
QPCR was performed using the Platinum SyBR Green QPCR
kit (Invitrogen BV) on a LightCycler System (Roche Applied
Science, Venlo, The Netherlands), as previously described
(46).
Protein Extraction and Western Blotting
Protein extraction, SDS-PAGE, and Western blotting were
performed as previously described (9). All blots were re-
peated at least three times, and one representative image is
shown. Relative optical densities were analyzed using Im-
ageJ software (NIH, Bethesda, MD) on images obtained from
three independent blots.
Immunoprecipitation Experiments
Human cervical carcinoma (HeLa) cells were transfected us-
ing Superfect following manufacturer’s instructions (QIAGEN
Benelux B.V., Venlo, The Netherlands). Transfected cells
were lysed as described above, and immunoprecipitation
from the cell lysates and Western blot detection were done
with the ExactaCruz F kit, following manufacturer’s instruc-
tions (Santa Cruz Biotechnology). The GR antibody (H300,
Santa Cruz Biotechnology) was used as immunoprecipitating
antibody. Rabbit nonimmune IgG was used as negative con-
trol for the immunoprecipitation step (SC-2027, Santa Cruz
Biotechnology). Both GR and DCL antibodies were used for
Western blot detection.
FRET Experiments
All imaging experiments were performed on a Digital Eclipse
C1si Spectral Laser Confocal System (Nikon, Badhoevedorp,
The Netherlands) equipped with Diode, multiline Argon, and
DPSS lasers (Melles Griot) attached to a TE2000E-PFS in-
verted microscope equipped with Perfect Focusing System
(Nikon). Expression levels of donor (EGFP) and acceptor
(EYFP) proteins were controlled by Western blot. Previous to
FRET experiments, cotransfected cells were fixed as de-
scribed above.
The EGFP-EYFP donor-acceptor pair was chosen based
on its increased sensitivity for FRET (47, 48). Therefore, spec-
tral imaging and linear unmixing for FRET analysis by sensi-
tized emission were done essentially as described by Zim-
mermann et al. (49), with some modifications. Emission
spectra of EGFP and EYFP were acquired from fixed cells
expressing only one of the fluorescent fusion proteins with
excitation wavelength of 457 and 488 nm, previously used to
excite EGFP as a FRET donor (47, 49). From these spectra
(supplemental Fig. 2) and available spectra for EYFP (http://
probes.invitrogen.com/resources/spectraviewer), EGFP was
excited by using the 457-nm and EYFP was excited by using
the 514 Ar laser lines, respectively. Fluorescence emission
was collected in spectral windows spanning from 470 to 500
and from 530 to 600 nm for EGFP and EYFP, respectively.
Calibration of the FRET conditions was performed using an
EYFP-EGFP fusion protein (47). Laser power and detector
gain were adjusted in the different settings to observe similar
concentrations of EGFP and EYFP, as calibrated by Western
blot. Settings were kept unchanged for analysis of all sam-
ples. EGFP and EYFP spectral bleed-through in FRET set-
tings were determined from cells expressing only EGFP-DCL
or EYFP-GR by calculating intensity ratios in the appropriate
settings (50) (IFRET/IDonor and IFRET/IAcceptor, respective-
ly; supplemental Fig. 2).
FRET intensities were then corrected for spectral bleed-
through and normalized (NFRET) for expression levels (50).
Reporter Gene Assays
GR-dependent transcriptional activity was measured in
transfected COS-1 cells and N1E-115 cells by using a Dual
Luciferase (Promega Corp., Madison, WI)-based GC re-
sponse element reporter gene assay as previously described
(44). Cells were cotransfected with indicated constructs and,
48 h after transfection, were treated overnight with DEX.
Results are expressed as mean GR transcriptional activity 
SEM of three independent experiments performed in triplicate.
Immunofluorescence and Laser-Scanning Confocal
Microscopy
Double/triple immunofluorescence and laser-scanning con-
focal microscopy in COS-1 cells, N1E-115 cells, and free-
floating tissue slices was done as previously described (9).
Analysis of intracellular localization was done with ImageJ
and expressed as a nuclear/cytosolic intensity ratio guided
by Hoechst 3342 stain as described previously (51). Expres-
sion of markers and localization were done counting at least
50 cells in the hilar region per slice. Fluorescent cell counting
was performed using ImageJ. Quantification of EGFP/GR
colocalization in processes of EGFP NPCs was done with
ImageJ (JACoP plugin). Images were transformed to 8 bits,
and a colocalization score representing the Overlap Coeffi-
cient R (52) was calculated. For experiments in N1E-115
cells, colocalization with tubulin was used.
Curve Fitting and Statistical Analyses
Dose-response and kinetic curve fitting and data analysis
were carried out by nonlinear regression using Prism 4.0 and
statistical analyses with InStat 3.0 (GraphPad Software, Inc.,
San Diego, CA). For dose-response curves, a sigmoidal
dose-response equation [Y  Bottom  (Top Bottom)/(1 
10(LogEC50  X)] was used, from which EC50 and maximal
effects were estimated. For kinetic curves a one-phase ex-
ponential association equation [Y  Ymax*(1  exp( K*X))]
was used, from which half-times and Ymax were estimated.
Unpaired t test (two groups) or one-way ANOVA test (three or
more groups) was applied as previously described (53) and a
P value  0.05 was considered significant in all cases.
More detailed descriptions of the materials and methods
used in this study are provided as supplemental data.
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